Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of T Cell Immunity in Monoclonal Gammopathy and Multiple Myeloma: From Immunopathogenesis to Novel Therapeutic Approaches. | Int J Mol Sci | 2022 | 35563634 | PubTator, text mining | PubMed |
| Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. | Am J Hematol | 2022 | 35560063 | PubTator, text mining | PubMed |
| Overcoming Cancer Drug Resistance Utilizing PROTAC Technology. | Front Cell Dev Biol | 2022 | 35547806 | PubTator, text mining | PubMed |
| Meis1 supports leukemogenesis through stimulation of ribosomal biogenesis and Myc. | Haematologica | 2022 | 35546301 | PubTator, text mining | PubMed |
| Dissecting the impact of bromodomain inhibitors on the Interferon Regulatory Factor 4-MYC oncogenic axis in multiple myeloma. | Hematol Oncol | 2022 | 35544413 | PubTator, text mining | PubMed |
| Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic. | Oncogene | 2022 | 35525905 | PubTator, text mining | PubMed |
| Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma. | Clin Cancer Res | 2022 | 35522533 | PubTator, text mining | PubMed |
| Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms. | Blood | 2022 | 35512188 | PubTator, text mining | PubMed |
| Large-conductance calcium-activated potassium channel haploinsufficiency leads to sensory deficits in the visual system: a case report. | J Med Case Rep | 2022 | 35509069 | PubTator, text mining | PubMed |
| CRISPR-Suppressor Scanning Unsticks Molecular Glues. | ACS Cent Sci | 2022 | 35505876 | PubTator, text mining | PubMed |
| Profiling the Landscape of Drug Resistance Mutations in Neosubstrates to Molecular Glue Degraders. | ACS Cent Sci | 2022 | 35505873 | PubTator, text mining | PubMed |
| Early Prediction and Evaluation of Risk of Autism Spectrum Disorders. | Cureus | 2022 | 35481307 | PubTator, text mining | PubMed |
| Biological impact of iberdomide in patients with active systemic lupus erythematosus. | Ann Rheum Dis | 2022 | 35477518 | PubTator, text mining | PubMed |
| Disrupting the HDAC6-ubiquitin interaction impairs infection by influenza and Zika virus and cellular stress pathways. | Cell Rep | 2022 | 35476995 | PubTator, text mining | PubMed |
| Design, synthesis, and molecular docking studies of novel pomalidomide-based PROTACs as potential anti-cancer agents targeting EGFRWT and EGFRT790M. | J Enzyme Inhib Med Chem | 2022 | 35470756 | PubTator, text mining | PubMed |
Combination Therapy of an Antibody Specific for Transferrin Receptor 1 (ch128.1/IgG1) With Bortezomib or Lenalidomide Results in Increased Survival in an In Vivo Model of Human Multiple Myeloma: A Brief Communication. | J Immunother | 2022 | 35467582 | PubTator, text mining | PubMed |
| Targeted Protein Degradation: An Important Tool for Drug Discovery for "Undruggable" Tumor Transcription Factors. | Technol Cancer Res Treat | 2022 | 35466792 | PubTator, text mining | PubMed |
| Non-Coding RNAs in Sepsis-Associated Acute Kidney Injury. | Front Physiol | 2022 | 35464083 | PubTator, text mining | PubMed |
| Lenalidomide induced secondary Acute Lymphoblastic Leukemia in a Multiple Myeloma patient: A case-report. | Leuk Res Rep | 2022 | 35462726 | PubTator, text mining | PubMed |
| Metabolic Vulnerabilities in Multiple Myeloma. | Cancers (Basel) | 2022 | 35454812 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=61